酮洛芬（奥鲁地）用于强直性脊柱炎的治疗。
Ketoprofen (Orudis) in ankylosing spondylitis.
作者信息
Treadwell B L, Tweed J M
出版信息
N Z Med J. 1975 May 14;81(539):411-3.
PMID:1099489
Abstract
A double-blind cross-over study is described in which ketoprofen (Orudis) is compared with phenylbutazone in 14 patients with ankylosing spondylitis. Results indicated a significant patient preference for phenylbutazone with greater improvement in the ESR. However, the absence of objective and laboratory deterioration with ketoprofen, when compared with the initial, or control, assessments, suggests that it may prove a useful alternative to phenylbutazone in spondylitic disease.
摘要
本文描述了一项双盲交叉研究，该研究将14例强直性脊柱炎患者的酮洛芬（奥鲁地）与保泰松进行了比较。结果表明，患者明显更倾向于保泰松，其红细胞沉降率（ESR）改善更大。然而，与初始评估或对照评估相比，酮洛芬没有出现客观和实验室指标恶化的情况，这表明在脊柱疾病中，酮洛芬可能是保泰松的一种有用替代药物。
Zotero 插件